The funding is intended to help gain further insights on ceramic materials, to develop a technology platform for safe dosing of opioids.
The project will make use of Uppsala University’s knowledge of material properties, while Orexo will provide with pharmaceutical expertise in controlled drug release and product development.
Orexo Pharmaceutical Research & Development Head Thomas Lundqvist said through the grant the company would develop a new technology platform for dosing of highly potent drugs.